
PraxisPro, a data intelligence company focused on Life Sciences, has closed an oversubscribed $6M seed round led by AlleyCorp. The investment round drew participation from Flybridge, South Loop Ventures, Zeal Capital Partners, True Ventures, Techstars, Alumni Ventures, and Daring Ventures.
The funding arrives as Life Sciences organizations grapple with fragmented and incomplete customer data that affects commercial decisions. These data gaps create compliance risks and limit opportunities to improve patient outcomes, problems that grow more expensive as regulatory requirements expand.
Life Sciences companies currently operate with disconnected information across their commercial teams. HCP engagement is declining while training costs rise due to regulatory pressures. PraxisPro tackles this problem by using purpose-built Small Language Models and AI agents designed specifically for therapeutic areas and disease states.
The company's Learning Experience Platform surfaces previously inaccessible datasets and creates continuity between pre-call planning, post-call insights, and out-of-territory education. This approach gives organizations a clearer view of field operations without adding operational burden.
PraxisPro will use the new capital to improve its core platform. Development priorities include streamlined therapeutic area and disease state SLMs, an enhanced mobile experience, and self-service capabilities. The company also plans to grow its team to support increasing customer demand.
The platform addresses rising costs and complexity in Life Sciences commercial operations. By serving as the commercial intelligence backbone across commercial, medical, and compliance functions, PraxisPro's models aim to enable disciplined execution at scale while keeping the focus on patient outcomes.
"As a former sales professional, training leader, and commercial operator, we're building the products I wish I had in every role I held," said Cam Badger, Founder and CEO of PraxisPro. "By using curated, purpose-built SLMs, we're helping Life Sciences teams generate the new data and insight they need to operate better, and ultimately make a greater difference for patients who rely on them."
PraxisPro's approach differs from general-purpose AI applications. The company uses industry-specific models with governed data that align with actual commercial workflows in Life Sciences organizations.
"PraxisPro is applying AI in a way that is truly native to Life Sciences. Purpose-built models, governed data, and a deep understanding of real commercial workflows make this platform and this team uniquely positioned to lead the category," said Omar Njie, Principal at AlleyCorp.
The investment reflects growing recognition that Life Sciences organizations need reliable, governed approaches to generating commercial intelligence. Generic LLM solutions often fall short of the specific compliance and operational requirements in healthcare and pharmaceutical sectors.

